Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.

Norikazu MatsuoKoichi AzumaKenta MurotaniDaiki MurataGoushi MatamaAkihiko KawaharaTakashi KojimaTakaaki TokitoTomoaki Hoshino

Published in: Thoracic cancer (2023)

In NSCLC patients, cachexia was associated with a worse prognosis, irrespective of tumor PD-L1 expression, indicating that cachexia is a predictive factor for NSCLC patients receiving immune checkpoint inhibitors.

Keyphrases

small cell lung cancer
end stage renal disease
newly diagnosed
ejection fraction
advanced non small cell lung cancer
chronic kidney disease
prognostic factors
brain metastases
patient reported
patient reported outcomes